Transplant Diagnostics Market: By Technology (Molecular Assay Technologies (PCR-Based Molecular Assays (Real-time PCR, Sequence-specific Primer-PCR, Sequence-specific Oligonucleotide-PCR, Other PCR-based Molecular Assays), Sequencing-based Molecular Assays (Sanger Sequencing, Next Generation Sequencing, Other Sequencing-based Molecular Assays), Non-molecular Assay Technologies), By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Transplant Type (Solid Organ Transplantation (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, Other Organ Transplantations), Stem Cell Transplantation, Soft Tissue Transplantation, Bone marrow Transplantation) By Application (Diagnostic Applications (Pre-transplantation Diagnostics, (Infectious Disease Testing, Histocompatibility Testing, Blood Profiling), Post-transplantation Diagnostics), Research Applications), By End User (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Transplant Diagnostics Market size was valued at USD 4.1 billion in 2022  and is poised to grow at a CAGR of 7.8% from 2022 to 2029. One of the main factors driving the expansion of the market under study is the increase in organ donation. In January 2021, more than 12,500 people donated one or more organs in 2020, up 6% from the year before, according to figures released by the Association of Organ Procurement Organizations (AOPO). Over 36,500 organs were donated from deceased donors in 2020, an increase of nearly 2% compared to the previous year. For the seventh consecutive year, these recovered organs saved more lives more than 33,000 than they did the year before. Donation after Circulatory Death (DCD) contributions also saw significant increases; they totalled more than 3,000 donors, an 18% rise from the previous year. Increased transplant diagnostic testing will result from increased organ donation, propelling market expansion. The diagnosis of pulmonary function and general health is emphasized much in the context of heart transplants. The diagnostics have considerably improved over the last ten years due to businesses dedicated themselves to creating better HLA typing technologies, antibody monitoring, equipment, and software. This is rapidly employed for diagnostic purposes during organ transplantation across various body parts. Multispecialty hospitals in developed markets are doing many more transplant procedures due to technical developments and expanding financial opportunities made possible by public-private partnerships. To assess the level of infection inside an organ, the diagnosis for transplantation is carried out at the donor and patient's ends. Additionally, several significant players are releasing new products on the market, which is anticipated to further fuel market expansion. For instance, in September 2021, Thermo Fisher Scientific added two new products to its range of transplant diagnostics during the American Society for Histocompatibility and Immunogenetics (ASHI) annual meeting.

Transplant Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Transplant Diagnostics Market Dynamics

A significant aspect driving demand for diagnostics before the surgery is the rise in organ transplants. There has always been a greater need for transplants than there are available organs. However, the market will likely profit from in-depth field studies and analyses to close this gap. An increase in the number of people with chronic illnesses that frequently cause organ failure is driving the rising demand for transplant surgeries. Personalized medicine and stem cell therapy are also becoming more popular, increasing the demand for transplant diagnostics. Improved and sophisticated diagnostic methods are required due to the risks and complexity of organ transplantation. Due to an increasing need for high-throughput diagnostic tools with improved accuracy, Next-Generation Sequencing (NGS) technology is quickly replacing traditional diagnostic approaches, such as serological techniques used in Human Leukocyte Antigen (HLA) type. However, the scarcity of available organs for transplant procedures, difficulties with HLA sequencing, and general ignorance restrain market expansion.

Transplant Diagnostics Market Segmentation

By Technology

  • Molecular Assay Technologies (PCR-Based Molecular Assays
  • Sequencing-based Molecular Assays
  • Non-molecular Assay Technologies

By Product Type

  • Reagents & Consumables
  • Instruments
  • Software & Services

 

By Transplant

  • Solid Organ Transplantation
  • Stem Cell Transplantation
  • Soft Tissue Transplantation
  • Bone marrow Transplantation

By Application

  • Diagnostic Applications
  • Diagnostics
  • Research Applications

By End User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories & Academic Institutes

Frequently Asked Questions

The transplant diagnostics market is projected to expand at a CAGR of 7.8% during the forecast period.

Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences

North America is the fastest-growing region for transplant diagnostics market

Key Features of the Report

  • The transplant diagnostics market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market
1. Executive Summary
2. Global Transplant Diagnostics Market Introduction 
2.1.Global Transplant Diagnostics Market  - Taxonomy
2.2.Global Transplant Diagnostics Market  - Definitions
2.2.1.Technology
2.2.2.Product Type
2.2.3.Transplant
2.2.4.Application
2.2.5.End User
3. Global Transplant Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Transplant Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Transplant Diagnostics Market  By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Molecular Assay Technologies (PCR-Based Molecular Assays
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Sequencing-based Molecular Assays
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Non-molecular Assay Technologies
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Transplant Diagnostics Market  By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Reagents & Consumables
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Instruments
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Software & Services
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Transplant Diagnostics Market  By Transplant, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Solid Organ Transplantation
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Stem Cell Transplantation
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Soft Tissue Transplantation
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Bone marrow Transplantation
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Transplant Diagnostics Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Diagnostic Applications
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostics
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Research Applications
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Transplant Diagnostics Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Independent Reference Laboratories
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Hospitals & Transplant Centers
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Research Laboratories & Academic Institutes
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
10. Independent Reference Laboratories Transplant Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Molecular Assay Technologies (PCR-Based Molecular Assays
10.1.2.Sequencing-based Molecular Assays
10.1.3.Non-molecular Assay Technologies
10.2.  Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Reagents & Consumables
10.2.2.Instruments
10.2.3.Software & Services
10.3.  Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Solid Organ Transplantation
10.3.2.Stem Cell Transplantation
10.3.3.Soft Tissue Transplantation
10.3.4.Bone marrow Transplantation
10.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Diagnostic Applications
10.4.2.Diagnostics
10.4.3.Research Applications
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Hospitals & Transplant Centers Transplant Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Molecular Assay Technologies (PCR-Based Molecular Assays
11.1.2.Sequencing-based Molecular Assays
11.1.3.Non-molecular Assay Technologies
11.2.  Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Reagents & Consumables
11.2.2.Instruments
11.2.3.Software & Services
11.3.  Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Solid Organ Transplantation
11.3.2.Stem Cell Transplantation
11.3.3.Soft Tissue Transplantation
11.3.4.Bone marrow Transplantation
11.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Diagnostic Applications
11.4.2.Diagnostics
11.4.3.Research Applications
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Research Laboratories & Academic Institutes Transplant Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Molecular Assay Technologies (PCR-Based Molecular Assays
12.1.2.Sequencing-based Molecular Assays
12.1.3.Non-molecular Assay Technologies
12.2.  Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Reagents & Consumables
12.2.2.Instruments
12.2.3.Software & Services
12.3.  Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Solid Organ Transplantation
12.3.2.Stem Cell Transplantation
12.3.3.Soft Tissue Transplantation
12.3.4.Bone marrow Transplantation
12.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Diagnostic Applications
12.4.2.Diagnostics
12.4.3.Research Applications
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.2.  Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Reagents & Consumables
13.2.2.Instruments
13.2.3.Software & Services
13.3.  Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Solid Organ Transplantation
13.3.2.Stem Cell Transplantation
13.3.3.Soft Tissue Transplantation
13.3.4.Bone marrow Transplantation
13.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Diagnostic Applications
13.4.2.Diagnostics
13.4.3.Research Applications
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.2.  Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Reagents & Consumables
14.2.2.Instruments
14.2.3.Software & Services
14.3.  Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Solid Organ Transplantation
14.3.2.Stem Cell Transplantation
14.3.3.Soft Tissue Transplantation
14.3.4.Bone marrow Transplantation
14.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Diagnostic Applications
14.4.2.Diagnostics
14.4.3.Research Applications
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.LXN Corporation
15.2.2.Horiba Medical
15.2.3.Alpha Laboratories
15.2.4.Cylex Inc
15.2.5.Otsuka Holdings Co Ltd
15.2.6.Laboratory Corporation of America Holdings
16. Research Methodology 
17. Appendix and Abbreviations 
  • LXN Corporation
  • Horiba Medical
  • Alpha Laboratories
  • Cylex Inc
  • Otsuka Holdings Co Ltd
  • Laboratory Corporation of America Holdings
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • TransMedics, Inc.
  • Medtronic
  • Hoffmann-La Roche Ltd.
  • Novartis AG
  • Zimmer Biomet
  • Pfizer Inc.
  • Preservation Solutions, Inc
  • Sanofi, Terumo Corporation
  • Stryker

Adjacent Markets